Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep473 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Insulin secretion several years after type 1 diabetes diagnosis: case reports

Margarida Monteiro Ana , Paredes Silvia , Alves Marta

Introduction: Currently, type 1 diabetes (T1D) is defined by the autoimmune destruction of the pancreatic β cells that culminates in dependence on exogenous insulin, typically 1–3 years after diagnosis. This ability to maintain a residual function of pancreatic β cells is, however, heterogeneous, appearing to be worst if the disease is early diagnosed. Recently, it was demonstrated that many type 1 diabetic patients produce small amounts of insulin decades after...

ea0041ep31 | Adrenal cortex (to include Cushing's) | ECE2016

Primary aldosteronism – results from the first Portuguese multicentre study

Nunes da Silva Tiago , Fernandes Vera , Martins Diana , Goncalves Diana , Almeida Raquel , Margarida Monteiro Ana , Neves Carolina , Simoes Helder , Marques Pedro , Alves Filipa , Pereira Maria

Primary Aldosteronism (PA) is the most prevalent cause of secondary hypertension. The aim of this work was to characterize the diagnostic workup, treatment and follow-up of confirmed PA.The adrenal tumour study group of the Portuguese Society of Endocrinology undertook the first retrospective multicentre study of Portuguese PA patients. Data was gathered from nine Portuguese Endocrinology centres (three in the north, one in the centre and five in the sou...

ea0070aep282 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Residual fasting C-peptide secretion and its association with glycemic control in type 1 diabetes

Lopes Sara , Barbosa Mariana , Barros Inês , Sá Juliana , Joana Santos Maria , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Lopes Pereira Maria , Marques Olinda , Alves Marta

Background: Residual C-peptide (CP) secretion has been associated with better glycemic control in patients with type 1 diabetes (T1D).Aim: To evaluate how residual fasting CP (fCP) secretion impacts glycemic control in T1D and to identify possible confounding factors.Methods: A retrospective analysis of adult patients with T1D followed in our department that had their fCP and glucose levels obtained on the same blood sample during ...

ea0070aep484 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Flash glucose monitoring system: Impact on glycaemic control and body mass index in type 1 diabetes mellitus

Sá Juliana , Lopes Sara , Barbosa Mariana , Ferreira Barros Inês , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Alves Marta , Lopes Pereira Maria , Marques Olinda , Joana Santos Maria

Background: The use of Flash Glucose Monitoring (FGM) for the management of type 1 diabetes mellitus (T1D) is rapidly increasing.Aims: To assess the longitudinal evolution of glycated haemoglobin (HbA1c) and body mass index (BMI) with the use of FGM in patients with T1D; to determine predictive factors of benefit with the use of this technology.Materials and methods: Retrospective study of T1D patients, using FGM ≥6 months an...